DND Technologies, Inc. (DNDT)
DND Technologies, Inc. operates in the Beverages - Non-Alcoholic industry of the Consumer Defensive sector, headquartered in New York City, NY, US. The stock last traded at $0.51, down 3.77% on the session, giving a market capitalisation of $1.6M. On trailing twelve-month figures it carries a trailing P/E of -850.00, a net margin of 0.0%. Its beta of -4.30 implies it has historically moved less than the broad market.
Headquartered in New York City, DND Technologies, Inc. was established in 1997. Operating as a holding company, DND Technologies specializes in the production and sale of diverse specialty balms. Beyond balms, the company is a key manufacturer and distributor of pharmaceutical goods. Its portfolio includes Bioassaygen Gel, formulated to diminish wrinkles and promote natural skin regeneration. The Bioassaygen Cosmetic Mask serves aesthetic enhancement purposes. Additionally, DND offers Bioassaygen Bio-Skin, an innovative skin replacement bandage, and Bioassaygen Delivery Gel, designed to accelerate natural skin renewal. These products reach consumers and businesses through a multi-channel distribution strategy, encompassing wholesale, retail outlets, and e-commerce platforms.
DND Technologies, Inc. is most often compared with the following Consumer Defensive names: